ArticleFrontiers in pharmacology2022

Absorption, Metabolism, and Excretion of ACT-1004-1239, a First-In-Class CXCR7 Antagonist:

Christine Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.